Registro:

Referencias:

• Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., (2013) GLOBOCAN 2012 V1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase. No. 11 [Internet], , Lyon, France: International Agency for Research on Cancer
• Quail, D.F., Joyce, J.A., Microenvironmental regulation of tumor progression and metastasis (2013) Nat Med, 19, pp. 1423-1437
• Corn, P.G., The tumor microenvironment in prostate cancer: Elucidating molecular pathways for therapy development (2012) Cancer Manag Res, 4, pp. 183-193
• Hanna, E., Quick, J., Libutti, S.K., The tumour microenvironment: A novel target for cancer therapy (2009) Oral Dis, 15, pp. 8-17
• Grivennikov, S.I., Greten, F.R., Karin, M., Immunity, inflammation, and cancer (2010) Cell, 140, pp. 883-899
• Mantovani, A., Allavena, P., Sica, A., Balkwill, F., Cancer-related inflammation (2008) Nature, 454, pp. 436-444
• Hanahan, D., Weinberg, R.A., Hallmarks of cancer: The next generation (2011) Cell, 144, pp. 646-674
• Jackson, J.R., Seed, M.P., Kircher, C.H., Willoughby, D.A., Winkler, J.D., The codependence of angiogenesis and chronic inflammation (1997) FASEB J, 11, pp. 457-465
• Mantovani, A., Molecular pathways linking inflammation and cancer (2010) Curr Mol Med, 10, pp. 369-373
• Gozzelino, R., Jeney, V., Soares, M.P., Mechanisms of cell protection by heme oxygenase-1 (2010) Annu Rev Pharmacol Toxicol, 50, pp. 323-354
• Wegiel, B., Nemeth, Z., Correa-Costa, M., Bulmer, A.C., Otterbein, L.E., Heme oxygenase-1: A metabolic nike (2014) Antioxid Redox Signal, 20, pp. 1709-1722
• Was, H., Dulak, J., Jozkowicz, A., Heme oxygenase-1 in tumor biology and therapy (2010) Curr Drug Targets, 11, pp. 1551-1570
• Grochot-Przeczek, A., Dulak, J., Jozkowicz, A., Haem oxygenase-1: Non-canonical roles in physiology and pathology (2012) Clin Sci, 122, pp. 93-103
• Gueron, G., De Siervi, A., Ferrando, M., Salierno, M., De Luca, P., Elguero, B., Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells (2009) Mol Cancer Res, 7, pp. 1745-1755
• Ferrando, M., Gueron, G., Elguero, B., Giudice, J., Salles, A., Leskow, F.C., Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer (2011) Angiogenesis, 14, pp. 467-479
• Ferrando, M., Wan, X., Meiss, R., Yang, J., De Siervi, A., Navone, N., Heme oxygenase-1 (HO-1) expression in prostate cancer cells modulates the oxidative response in bone cells (2013) PLoS One, 8, p. e80315
• Gueron, G., Giudice, J., Valacco, P., Paez, A., Elguero, B., Toscani, M., Hemeoxygenase-1 implications incell morphology and the adhesive behavior of prostate cancer cells (2014) Oncotarget, 5, pp. 4087-4102
• Paez, A., Pallavicini, C., Schuster, F., Valacco, M.P., Giudice, J., Ortiz, E.G., Heme oxygenase-1 at the forefront of a multi-molecular network that governs cell-cell contact and filopodia-induced zippering in prostate cancer (2016) Cell Death Dis, 7, p. e2570
• Elguero, B., Gueron, G., Giudice, J., Toscani, M.A., De Luca, P., Zalazar, F., Unveiling the association of STAT3 and HO-1 in prostate cancer: Role beyond heme degradation (2012) Neoplasia, 14, pp. 1043-1056
• Alaoui-Jamali, M.A., Bismar, T.A., Gupta, A., Szarek, W.A., Su, J., Song, W., A novel experimental heme oxygenase-1-targeted therapy for hormonerefractory prostate cancer (2009) Cancer Res, 69, pp. 8017-8024
• Li, Y., Su, J., DingZhang, X., Zhang, J., Yoshimoto, M., Liu, S., PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome (2011) J Pathol, 224, pp. 90-100
• Wegiel, B., Gallo, D., Csizmadia, E., Harris, C., Belcher, J., Vercellotti, G.M., Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth (2013) Cancer Res, 73, pp. 7009-7021
• Laderach, D.J., Gentilini, L.D., Giribaldi, L., Delgado, V.C., Nugnes, L., Croci, D.O., A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease (2013) Cancer Res, 73, pp. 86-96
• Li, Z.G., Mathew, P., Yang, J., Starbuck, M.W., Zurita, A.J., Liu, J., Androgen receptor - Negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms (2008) J. Clin. Invest, 118, pp. 2697-2710
• Croci, D.O., Cerliani, J.P., Dalotto-Moreno, T., Méndez-Huergo, S.P., Mascanfroni, I.D., Dergan-Dylon, S., Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors (2014) Cell, 156, pp. 744-758
• Rhodes, D.R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., ONCOMINE: A cancer microarray database and integrated data-mining platform1 (2004) Neoplasia, 6, pp. 1-6
• Gentilini, L.D., Jaworski, F.M., Tiraboschi, C., Gonzalez Perez, I.G., Kotler, M.L., Chauchereau, A., Laderach, D., Stable and high expression of galectin-8 tightly controls metastatic progression of prostate cancer (2017) Oncotarget, , May 18 [Epub ahead of print]
• Ellerhorst, J., Troncoso, P., Xu, X.C., Lee, J., Lotan, R., Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer (1999) Urol Res, 27, pp. 362-367
• Jouve, N., Despoix, N., Espeli, M., Gauthier, L., Cypowyj, S., Fallague, K., The involvement of CD146 and its novel ligand galectin-1 in apoptotic regulation of endothelial cells (2013) J Biol Chem, 288, pp. 2571-2579
• Jiang, T., Zhuang, J., Duan, H., Luo, Y., Zeng, Q., Fan, K., CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis (2012) Blood, 120, pp. 2330-2339
• Blancou, P., Tardif, V., Simon, T., Remy, S., Carreno, L., Kalergis, A., Immunoregulatory properties of heme oxygenase-1 (2011) Methods Mol Biol, 677, pp. 431-447
• Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36, pp. 322-335
• Grasso, C.S., Wu, Y.-M., Robinson, D.R., Cao, X., Dhanasekaran, S.M., Khan, A.P., The mutational landscape of lethal castration-resistant prostate cancer (2012) Nature, 487, pp. 239-243
• Bouma-Ter Steege, J.C.A., Baeten, C.I.M., Thijssen, V.L.J.L., Satijn, S.A., Verhoeven, I.C.L., Hillen, H.F.P., Angiogenic profile of Breast carcinoma determines leukocyte infiltration (2004) Clin Cancer Res, 10, pp. 7171-7178
• Vítek, L., Gbelcovâ, H., Muchovâ, L., Vâñova, K., Zelenka, J., Koníckovâ, R., Antiproliferative effects of carbon monoxide on pancreatic cancer (2014) Dig Liver Dis, 46, pp. 369-375
• Ahmad, S., Hewett, P.W., Fujisawa, T., Sissaoui, S., Cai, M., Gueron, G., Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation (2015) Thromb Haemost, 113, pp. 329-337
• Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tu morigenes is in kaposi's sarcoma (2012) J Exp Med, 209, pp. 1985-2000
• Szade, A., Grochot-Przeczek, A., Florczyk, U., Jozkowicz, A., Dulak, J., Cellular and molecular mechanisms of inflammation-induced angiogenesis (2015) IUBMB Life, 67, pp. 145-159
• Stenzel, K., Rubin, A., Novogrodsky, A., Mitogenicandco-mitogenicproperties of hemin (1981) J Immunol, 127, pp. 2469-2473
• Graca-Souza, A.V., Arruda, M.A.B., De Freitas, M.S., Barja-Fidalgo, C., Oliveira, P.L., Neutrophil activation by heme: Implications for inflammatory processes (2002) Blood, 99, pp. 4160-4165
• Figueiredo, R.T., Fernandez, P.L., Mourao-Sa, D.S., Porto, B.N., Dutra, F.F., Alves, L.S., Characterization of heme as activator of toll-like receptor 4 (2007) J Biol Chem, 282, pp. 20221-20229
• Porto, B.N., Alves, L.S., Fernandez, P.L., Dutra, T.P., Figueiredo, R.T., Graca-Souza, A.V., Heme induces neutrophil migration and reactive oxygen species generation through signaling pathways characteristic of chemotactic receptors (2007) J Biol Chem, 282, pp. 24430-24436
• Schulz, S., Chisholm, K., Zhao, H., Kalish, F., Yang, Y., Wong, R., Heme oxygenase-1 confers protection and alters T-cell populations in a mouse model of neonatal intestinal inflammation (2015) PediatrRes, 77, pp. 640-648
• Konrad, F., Knausberg, U., Hone, R., Ngamsri, K.-C., Reutershan, J., Tissue heme oxygenase-1 exerts anti-inflammatory effects on LPS-induced pulmonary inflammation (2016) Mucosal Immunol, 9, pp. 98-111
• Nemeth, Z., Li, M., Csizmadia, E., Döme, B., Johansson, M., Person, J., Heme oxygenase-1 in macrophages controls prostate cancer progression (2015) Oncotarget, 6, pp. 33675-33688
• Halin Bergstrom, S., Halin Bergstrom, S., Nilsson, M., Adamo, H., Thysell, E., Jernberg, E., Extratumoral heme oxygenase-1 (HO-1) expressing macrophages likely promote primary and metastatic prostate tumor growth (2016) PLoS One, 11, p. e0157280
• Jais, A., Einwallner, E., Sharif, O., Gossens, K., Lu, T.T.H., Soyal, S.M., Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man (2014) Cell, 158, pp. 25-39
• Mashreghi, M.-F., Klemz, R., Knosalla, I.S., Gerstmayer, B., Janssen, U., Buelow, R., Inhibition of dendritic cell maturation and function is independent of heme oxygenase 1 but requires the activation of STAT3 (2008) J Immunol, 180, pp. 7919-7930
• Rabinovich, G.A., Toscano, M.A., Turning "sweet" on immunity: Galectinglycan interactions in immune tolerance and inflammation (2009) Nat Rev Immunol, 9, pp. 338-352

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------